Arena Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 47   

Articles published

ARNA 4.04 +0.07 (1.76%)
price chart
Buy Arena Before European Approval Comes Through
Arena Pharmaceutical (NASDAQ:ARNA), a company operating in the healthcare sector, is involved in developing and commercializing drugs that target 'G-protein coupled receptors'.
A Valuation Model For Arena's Belviq
With Arena Pharmaceuticals' (ARNA) Belviq finally approved, Arena will be transitioning from being a cash-starved biotech into an earnings-generating one.
The Potential Market For Arena's Belviq
... because the product the company we invest in has real potential. There is a substantial difference between potential market and the real market for any given product.
What Slims Down Fastest After Diet Drugs Are Approved by he FDA? Two Stocks ...  YCharts
Short Interest in Biotech Firms on the Rise
Short interest data has been released from the August 15 settlement date. Overall short sellers have continued to bet on biotech firms compared to the July 31 settlement date.
Arena: Was This Pharmaceutical Stock a Pump and Dump?
These companies cannot be judged on their balance sheet because future earnings depend on FDA approval and successful sales and marketing.
Simple Math Showing Why Synergy Pharmaceuticals Is Undervalued
In prior articles I've talked about Synergy Pharmaceuticals (NASDAQ:SGYP) as a fantastic under-the-radar biotech stock for 2012.
Shattered Trust | Watchdog Update Hartland wipes manufacturer Triad files for ...
Triad Group Inc. and sister company H&P Industries Inc. are seeking protection from creditors under Chapter 11 - a provision that enables financially troubled firms to negotiate down their debts and continue in business.
Can Designers And Developers Save Health Care?
Participants who lost 7% of their body weight through dietary changes and increased physical activity dramatically diminished their chances of developing diabetes, soundly defeating the pharmaceuticals. So how was this life-changing intervention ...
SEC Subpoenas Teva Pharmaceutical in Bribery Probe
Teva, Israel's largest company by revenue, is the latest to come under scrutiny in a three-year-old U.S. government investigation of the pharmaceutical industry's compliance with the Foreign Corrupt Practices Act, a 1977 law that bars companies from ...
New anti-flu drugs could be on the market within years after scientists create ...
Now EMBL scientists are working with EMBL's spin-off company Savira pharmaceuticals, in partnership with Roche, to further develop anti-flu drugs.